A biological process for the production of xylonic acid (XA) from xylose or from xylose-rich lignocellulosic hydrolysates has been patented by BERG-iBB researchers Teresa Cesário, Manuela Fonseca and Maryna Bondar (PT 115970). The ability of the wild strain Paraburkholderia sacchari (previously classified as Burkholderia sacchari) DSM 17165 to produce xylonic acid from renewable and sustainable feedstocks is claimed. XA is a potential substitute for gluconic acid (GA), namely in the pharma industry, as a chelating agent, as a precursor of 1,2,4-butanetriol, polyamides and polyesters, as well as in the production of solvents, paints, adhesives and dyes. Moreover, XA, like GA, can be used as a retardant of the setting time of cement paste. XA productivities in the range 4.8 g/(L.h) to 7.1 g/(L.h) and yields between 89% e 100% were achieved, with XA titres of 360 to 390 g/L, using one single, non-pressurised stirred tank reactor operating in the fed-batch mode under dissolved oxygen concentrations higher than 10% saturation.
Your new post is loading...